Posted in | News | Business

Alpha Technologies Grows Capabilities and Global Reach with Metravib Material Testing Acquisition

Alpha Technologies, a global leader in rheology testing instrumentation, announced today it has acquired Metravib Material Testing, a specialist in dynamic mechanical analysis (DMA) and fatigue testing. The acquisition brings together two trusted names in material testing to expand global capabilities, improve customer support, and drive product innovation for research and industrial laboratories around the world. Alpha purchased Metravib Material Testing from the Acoem Group, a producer in AI-powered sensors and systems based in Limonest, France.​​​​​​​

Image Credit: Alpha Technologies

"This acquisition underscores our commitment to deliver the most comprehensive and reliable material testing solutions available," said Neil Friery, President of Alpha Technologies. "Combining Metravib's technologies and expertise with our own enables us to support critical customer needs with even greater precision.

Bringing together Alpha Technologies and Metravib Material Testing creates an unmatched portfolio of material testing solutions, including rheology, DMA, viscoelastic property characterization, failure analysis, fatigue performance evaluation, and thermo-mechanical analysis.

Customers will benefit from broader access to advanced instruments, streamlined support, and expanded global field service coverage. The integration of Metravib's technologies, including automated specimen handling systems and crack growth testing modules, will enhance research capabilities and accelerate product development timelines. These improvements support manufacturers' goals of optimizing operational efficiency, improving product quality, and reducing time to market.

"This strategic move is a testament to the remarkable journey and renowned expertise that Acoem has cultivated within the DMA activity", said Fabien Condemine, CEO Acoem. "Recognizing this strong foundation, we are confident that Alpha Technologies, with its deep understanding of the materials analysis market and extensive international presence, provides the ideal environment for it to thrive and achieve its full potential. This strategic decision also enables Acoem to further strengthen our focus on our core business of environmental and reliability solutions."

The acquisition immediately expands the material testing options available to Alpha and Metravib customers, supported by a larger team of experienced field service technicians and global applications experts. Customers can expect the same trusted performance and expertise they rely on today, backed by enhanced resources and an even stronger commitment to delivering confidence in every result.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Alpha Technologies. (2025, July 03). Alpha Technologies Grows Capabilities and Global Reach with Metravib Material Testing Acquisition. AZoM. Retrieved on July 03, 2025 from https://www.azom.com/news.aspx?newsID=64721.

  • MLA

    Alpha Technologies. "Alpha Technologies Grows Capabilities and Global Reach with Metravib Material Testing Acquisition". AZoM. 03 July 2025. <https://www.azom.com/news.aspx?newsID=64721>.

  • Chicago

    Alpha Technologies. "Alpha Technologies Grows Capabilities and Global Reach with Metravib Material Testing Acquisition". AZoM. https://www.azom.com/news.aspx?newsID=64721. (accessed July 03, 2025).

  • Harvard

    Alpha Technologies. 2025. Alpha Technologies Grows Capabilities and Global Reach with Metravib Material Testing Acquisition. AZoM, viewed 03 July 2025, https://www.azom.com/news.aspx?newsID=64721.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.